Biomarkers of cardiovascular disease risk in women

Area of Science:

• Cardiology
• Preventive Medicine
• Biomarker Research

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in the U.S. for both women and men.
• Traditional risk factors and models offer good but imperfect prediction of future CVD events.
• There is a growing need for novel biomarkers to enhance CVD risk assessment.

Purpose of the Study:

• To review traditional cardiovascular risk factors, prediction tools, and novel biomarkers for CVD risk in women.
• To highlight the need for further research on novel biomarkers in women's primary prevention.
• To examine the role of sex differences and unique exposures in cardiovascular outcomes for women.

Main Methods:

• Literature review of established and emerging cardiovascular risk factors.
• Analysis of risk prediction models and their limitations.
• Evaluation of novel biomarkers such as alternative lipids, natriuretic peptides, troponin, coronary artery calcium, and genetic markers.
• Consideration of sex-specific physiological differences and exposures.

Main Results:

• Traditional risk factors are insufficient for perfect CVD prediction.
• Novel biomarkers show promise but require further investigation, especially in women's primary prevention.
• Sex differences in metabolic syndrome and unique female exposures may influence CVD risk.

Conclusions:

• Novel biomarkers and a deeper understanding of sex-specific factors are crucial for improving CVD risk prediction in women.
• Further research is needed to validate the utility of novel biomarkers and address sex-specific nuances in CVD.
• Integrating novel markers and considering unique female exposures can refine cardiovascular risk assessment.